Bevespi Aerosphere (formoterol / glycopyrronium)
Indication
a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
Green
Brand:
Bevespi Aerosphere
Nice TA:
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Respiratory system
Background
Recommendation
LSCMMG Recommendation:
Green
Reason for decision:
Suitable for initiation in primary care
Supporting documents: